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Abstract
Background: Whether epidural analgesia for labor prolongs the active-first and second labor
stages and increases the risk of vacuum-assisted delivery is a controversial topic. Our study was
conducted to answer the question: does lumbar epidural analgesia with lidocaine affect the
progress of labor in our obstetric population?
Method:  395 healthy, nulliparous women, at term, presented in spontaneous labor with a
singleton vertex presentation. These patients were randomized to receive analgesia either, epidural
with bolus doses of 1% lidocaine or intravenous, with meperidine 25 to 50 mg when their cervix
was dilated to 4 centimeters. The duration of the active-first and second stages of labor and the
neonatal apgar scores were recorded, in each patient. The total number of vacuum-assisted and
cesarean deliveries were also measured.
Results: 197 women were randomized to the epidural group. 198 women were randomized to
the single-dose intravenous meperidine group. There was no statistical difference in rates of
vacuum-assisted delivery rate. Cesarean deliveries, as a consequence of fetal bradycardia or
dystocia, did not differ significantly between the groups. Differences in the duration of the active-
first and the second stages of labor were not statistically significant. The number of newborns with
1-min and 5-min Apgar scores less than 7, did not differ significantly between both analgesia groups.
Conclusion: Epidural analgesia with 1% lidocaine does not prolong the active-first and second
stages of labor and does not increase vacuum-assisted or cesarean delivery rate.
Background
Labor pain is a common phenomenon that can be miti-
gated by pharmacological and non-pharmacological
methods. Epidural techniques can be used to provide
complete analgesia during labor [1,2], but some authors
believe that epidural analgesia prolongs labor [2-4], and
can increase the need for instrumental [1,3,4], or cesarean
delivery [5-8].
We performed a controlled trial of 395 nulliparous
women who were randomized to either epidural analgesia
or single dose intravenous meperidine for pain relief dur-
ing labor. Our primary purpose was to determine whether
the use of 1% lidocaine for epidural analgesia during
labor affects duration of second labor stage. Our second-
ary purposes were the rate of cesarean delivery and neona-
tal apgar score, vacuum-assisted delivery rate, and
duration of active-first stage of labor.
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Methods
The study protocol was developed in collaboration with
obstetricians at Kashan University of Medical Sciences
(KAUMS) and approved by Kashan University of Medical
Sciences ethics commitee. Between June 2004 and Febru-
ary 2005, an independent research assistant approched all
nulliparous women that met our study inclusion criteria,
when these patients were admitted to the maternity unit
in Shabih-Khani Hospital, Kashan, Iran. Eligible patients
were provided with written and verbal information about
the study. Those patients that did not express interest in a
particular form of analgesia were enrolled into the study,
after they signed witnessed informed consent.
The inclusion criteria included nulliparity, active labor,
cervical dilatation < or = 4 centimeters, single fetus with
vertex presentation, ASA Status = 1, and request for anal-
gesia. Exclusion criteria included ASA status ≥2, age <19
years-old, receiving analgesia prior to enrollment, multi-
parity, probable cephalopelvic disproportion on pelvic
examination, and cervical dilatation to >4 centimeters.
Enrolled patients were randomly assigned to receive either
epidural or single dose meperidine analgesia during labor.
Odd and even numbers were used to allocate patients to
either group. All parturients were managed by a nurse
anesthetist, under the direct supervision of an anesthesiol-
ogist according to the study protocol.
Midwives conducted the obstetric management of all par-
turients during labor, under the direct supervision of an
obstetrician according to the study protocol. Routine
intrapartum management of all women included intrave-
nous fluid management and auscultation of the fetal heart
with fetal stethoscope or ultrasound fetal heart detector
(SONICAID©) after each uterine contraction. The fre-
quency and duration of uterine contractions were assessed
with the palm of the hand on the uterus. Pelvic examina-
tion was performed every hour to evaluate the progress of
labor. The aim was to produce a rate of cervical dilation of
at least 1 cm/h. When the rate of dilation fell below this,
coincidental with hypotonic uterine contractions, oxy-
tocin in a concentration of 10 unit/liter was started at a
rate of 6 milliunits/min, increased by 3 milliunits/min at
15-min intervals up to a maximum of 32 milliunits/min
and titrated to allow no more than 3 uterine contractions
with an acceptable resting duration every 10 minutes.
A Modified Bromage score(1 = complete block, unable to
move feet or knee; 2 = almost complete block, able to
move feet only; 3 = partial block, just able to move knee;
4 = detectable weakness of hip flexion; 5 = no detectable
weakness of hip flexion while supine with full flexion of
knees) was obtained before and epidural insertion and
again at hourly intervals.
Dystocia was diagnosed when adequate uterine activity
did not result in progressive cervical dilation or descent of
the fetal head. Indications for the use of vacuum were lim-
ited to inadequate voluntary pushing or fetal bradycardia.
Inadequate voluntary pushing was determined at the bed-
side when lack of fetal descent due to inadequate maternal
expulsive efforts was observed. In the presence of fetal
bradycardia, delivery was expedited when the leading
point of the fetal skull was at +2 station.
In the epidural group, once cervical dilatation reached 4
cm, 500 ml of Ringer solution was administered intrave-
nously, and the parturient was seated in the upright posi-
tion for epidural placement. The low back was prepared
and draped in a sterile fashion. An 18-gauge Tuohy needle
was inserted at the L3–L4 or L4–L5 interspace with the
loss of resistance to air and an epidural catheter (SIMS
Portex LTD, UK) was advanced. A 3-ml test dose of 1.5%
lidocaine containing epinephrine 15 μg was used to
exclude intravascular or subarachnoid placement. A 10-
ml bolus of 1% lidocaine was administered via the epi-
dural catheter as a loading dose. Mini-doses of 1% lido-
caine were then administered at a rate of 1 ml every 6 min.
Additional boluses of 2-ml 1% lidocaine were injected to
overcome inadequate analgesia and to achieve a bilateral
block between the T-10 and T-8 sensory level. The study
ended at the time of vaginal delivery, spontaneous or with
vacuum extraction, or when the decision was made to per-
form a cesarean delivery for any reason. If additional anal-
gesia was needed during labor, 2 ml of 1% lidocaine
solution were administered epidurally. If anesthesia was
needed for assisted delivery or episiotomy, 5 ml of 2%
lidocaine was given. Hypotension, defined as a decrease
in systolic arterial blood pressure below 110 mm/Hg, was
managed with left uterine displacement, increased intra-
venous fluid replacement, or 5 mg ephedrine boluses. Fol-
lowing the induction and bolus doses of epidural
lidocaine, blood pressures and sensory blockade levels
were assessed every minute for 15 minutes and every 10
minutes, thereafter. Maternal oxyhemoglobin saturation
and heart rate were monitored with pulse oximetry.
In the single dose meperidine group, meperidine 25–50
mg (~0.5 mg/kg) was given intravenously at 4 cm uterine
cervical dilatation.
The mode of delivery (spontaneous, vacuum, cesarean)
was recorded. Forceps delivery is not a common proce-
dure in our center.
Statistical analysis
A power analysis was performed for the primary outcome
of interest on the basis of our patients, ie, duration of the
second labor stage. On the basis of institutional data, I
estimated a sample size of 197 women by group with anBMC Anesthesiology 2006, 6:15 http://www.biomedcentral.com/1471-2253/6/15
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assumed standard deviation of 100 minutes, based on my
experience significant difference between mean of the
groups at least 28 minutes, gives power of 80%, and a 2-
tailed alpha error of 0.05. Demographic variables were
assessed using descriptive statistics. The Mann-Whitney U
test was used to compare cervical dilatation rate and sec-
ond-stage durations. Other outcomes were evaluated
using unpaired student t  test, chi-square analysis, and
Fisher exact test as appropriate. P < 0.05 was considered
significant.
Results
A total of 395 healthy, nulliparous parturients with a sin-
gle gestation and an uneventful pregnancy in spontaneous
labor were randomized in this investigation. All women
completed the study as allocated. None of these patients
crossed over to the epidural analgesia group. Women in
both groups were similar in both obstetric and demo-
graphic characteristics as demonstrated in table 1. Admin-
istration of epidural analgesia with 1% lidocaine do not
prolong the active-first or second stages of labor signifi-
cantly, and do not increase the incidence of oxytocin aug-
mentation(Table 2).
There was no difference between groups in the incidence
of vacuum-assisted or cesarean deliveries(table 3). The
rate of vaginal delivery was not statistically different
between the study groups, as well.
As shown in table 4, infant outcome showed no evidence
that the type of analgesia had any adverse effects on neo-
natal Apgar scores. The number of neonates that pre-
sented with Apgar scores below 7 at one and five minutes
were not statistically different, between both groups. No
neonate needed naloxone or ICU admission.
We had no crossover from meperidine to epidural analge-
sia group.
No patient in meperidine group had lower extremity
motor weakness at any time as measured by modified Bro-
mage score. All patients from epidural group had a modi-
fied Bromage score of 2 throughout labor and delivery.
The preanalgesic visual analog pain scale scores were sim-
ilar between the two study groups (epidural, 9 ± 1.2 vs.
intravenous meperidine, 9 ± 1.3; P = 0.09). Women who
received epidural analgesia reported lower pain scores
during the first stage (epidural, 3 ± 3 vs. meperidine, 6 ± 4;
P < 0.0001) and second stage (epidural, 4 ± 3 vs. meperi-
dine, 8 ± 2; P < 0.0001) of labor. Women who received
epidural analgesia had a significantly higher incidence of
hypotension compared with women who received intra-
venous meperidine (30% vs. 0; P < 0.0001). There was no
significant difference in the incidence of nausea and vom-
iting between the two groups (epidural 6% vs. meperidine
4%). There were 5 accidental dural puncture among epi-
dural group (2%). There was no case of incomplete anal-
gesia or urinary retention.
Discussion
This investigation shows that the well-known muscle
relaxant effect of epidural lidocaine did not affect the
length of labor in a woman who receives epidural rather
than single dose meperidine analgesia. Also, lumbar epi-
dural analgesia using lidocaine was not associated with an
increased number of vacuum-assisted or cesarean deliver-
ies in our patient population: an academic hospital set-
ting, in a developing nation.
Since the introduction of inhalational analgesia into
obstetric practice in 1847, anesthesia for childbirth has
undergone constant change. The popularity of epidural
analgesia for childbirth is a recent phenomenon [9]. It is
accepted that lumbar epidural analgesia is the most effec-
tive method of pain relief in labor, but its putative effects
on labor and mode of delivery may influence clinical
practice.
Some practitioners will not continue epidural analgesia
into the second stage of labor or during childbirth [10],
despite lack of data for this practice [11]. They believe that
maternal efforts can also be impaired. Conversly, I con-
tinue epidural analgesia into the second stage of labor and
childbirth, so the mother could be entirely free of pain:
pain relief enabled the mother to cooperate in pushing
effectively.
Lidocaine is abandoned from epidural labor analgesia
because of its motor blocking properties. Epidural analge-
sia has been said to worsen obstetric outcome because of
motor block, and it is thus intuitively clear that lidocaine
is not the best drug to use in this situation. However, the
evidence linking motor block and obstetric outcome is
not as strong as often thought. For example, Evron et al.
[12], in a recent prospective, randomized double blinded
study showed that the lower intensity of the motor block
is not associated with any benefit in terms of obstetric out-
comes, duration of the second stage of labor, and obstetric
intervention. The only high quality study of the effect of
epidural analgesia using lidocaine on obstetric outcomes
was by Chestnut et al. [13], concluded that maintenance
of continuous epidural infusion of lidocaine did not pro-
long the second stage of labor.
Despite the belief that links motor blocking properties of
epidural analgesia to increased instrumental delivery rate,
I did not find such correlation. Also there are some stud-
ies, in which least concentrated doses of local anestheticBMC Anesthesiology 2006, 6:15 http://www.biomedcentral.com/1471-2253/6/15
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are used for epidural labor analgesia, and patients were
able to walk, but instrumentation rate was increased [14].
Bofill et al. [15], found that the incidence of instrumental
vaginal delivery for dystocia was not increased among epi-
dural patients and that the total increase in instrumental
vaginal delivery could have been partially due to the con-
duct of instrumented deliveries for training purposes. Per-
haps there was no correlation between epidural analgesia
and vacuum-assisted delivery.
Even though forceps delivery is not a common procedure
at our center, our results suggest that the rate of instru-
mental delivery should not increase with epidural analge-
sia.
In contrast to my study, Zhang et al. [2] found that the rate
of vacuum extraction increases notably but the overall rate
of instrumental delivery was not increased with epidural
analgesia for labor. Conversly, Sharma et al. [3] found that
significantly more women randomized to epidural anal-
gesia had forceps delivery in comparison with women
receiving intravenous opioid. Perhaps such differences are
the result of different management and decision making
for performing instrumental delivery. The results of the
current study suggest that spontaneous delivery is more
the result of obstetric management and that epidural anal-
gesia (even with a drug which has not the best theoretical
properties) has only minor influence. I continue and
sometimes augment analgesia in the second stage of labor
and during delivery; therefore a pain free mother can
cooperate more fully and can push more effectively. This
may work as a, harmless instrumentation, and may neu-
tralize the motor blocking effect of lidocaine. Although
this seems true in normal patients, dystotic labor may
benefit from the absence of motor block. This however
remains to be shown.
Because cesarean delivery carries greater anesthetic and
surgical risks than normal vaginal delivery, an increased
cesarean section rate secondary to epidural analgesia
could adversely affect the opinion of anesthesiologists
and obstetricians. Our investigation demonstrated that
the rate of cesarean delivery for dystocia or fetal bradycar-
dia is not increased as a result of labor epidural analgesia.
Many studies support this conclusion [1-3,16].
A recent systematic review found that epidural analgesia,
using low concentraton infusions of bupivacaine, is
unlikely to increase the risk of cesarean section [14].
A few reports, prior to 2000 found that epidural analgesia
was associated with an increased frequency of cesarean
delivery compared with systemic opioid analgesia [5,6].
Most of these reports have methodological flaws or selec-
tion biases that contribute to an increased cesarean sec-
tion rate. Retrospective data collection, to examine the
effect of lumbar epidural analgesia on labor outcomes,
has a selection bias. For instance, a woman choosing epi-
dural analgesia may be in greater pain; however, this
greater pain may be due to a difficult labor, which implic-
itly poses an increased risk of dystocia and consequently,
cesarean delivery [17,18].
In a recent prospective study, Illuzzi et al. [7] found that
epidural analgesia was associated with an increased risk of
Table 2: Progress of labor
Labor progress Epidural N = 197 Meperidine N = 198 P value
Active phase of first Stage of labor (h) 2.49 ± 1.40 2.40 ± 1.55 NS
Second stage (h) 1.04 ± 0.69 0.86 ± 0.71 NS
Oxytocin augmentation After initiation of Analgesia 197(100) 192(96) NS
Rate of cervical dilatation (cm/h) 0.53 ± 0.2 0.54 ± 0.2 NS
Fever ≥ 38°C 43(22) 13(7) <0.001
Data are Mean ± SD Standard Deviation
Or N (%)
NS = Not Significant
Table 1: Maternal Demographics Characteristics
Factor Epidural Analgesia N = 197 Meperidine Analgesia N = 198 P value
Age(yr) 23.2 ± 2 22.03 ± 3 NS
Height(cm) 154 ± 9 155 ± 9 NS
Weight(kg) 74 ± 12 74 ± 13 NS
Gestational Age (wk) 38 ± 2 39 ± 1 NS
Data are Mean ± SD Standard Deviation
NS = Not SignificantBMC Anesthesiology 2006, 6:15 http://www.biomedcentral.com/1471-2253/6/15
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fetal malrotation and cesarean delivery. Prospective stud-
ies also have some limitations. Many women have firm
views on the type of analgesia they prefer in labor and are
reluctant to consent to receive a method of analgesia at
random. Women who are well educated, assured, and
have mature personalities are at increased risk of obstetric
intervention, such as epidural anesthesia [19]. They may
choose obstetric care based on perceived access to pain
relief [20].
Conversely, some women believe that labor pain is essen-
tial to the birthing experience – these patients will forego
any analgesic intervention in order to have a completely
'natural' childbirth. They believe that labor pain is God's
favor; they would like to acquire spiritual reward, so they
are unwilling to receive any analgesic intervention.
The incidence of the cesarean sections in this study is low
in both study groups. This may be due to the fact that we
initiated analgesia at exact 4 centimeters of uterine cervi-
cal dilatation.
Also lidocaine is not as expensive as bupivacaine, the
chances of severe complications are less than bupivacaine.
Though in cases of delay placement of epidural analgesia,
its rapid onset of action compared with bupivacaine is
beneficial. Perhaps, for epidural labor analgesia, lidocaine
is disproportionately criticized.
There are some limitations to this study: physician
assisted delivery of mini-doses of epidural lidocaine may
not be practical in developed countries. Nonetheless, in
developing countries certain drugs and infusion pumps
may not be readily available. A characteristics of this study
is the disparity in the quality of pain relief between epi-
dural analgesia and single dose meperidine analgesia
groups, which would have been made blinding of clini-
cians impossible. Additionally, we cannot quantify the
impact of a placebo response, engendered by having a
physician standing continuously alongside a parturient.
Epidural analgesia for labor is not widely practiced in
developing countries and is often not offered to immi-
grants from the developing world [21-23]. In fact, access
to pain relief during labor, in some developing countries,
is poor [21]. Patients may demand pain relief, but provid-
ers may not recognize the need [21,22]. Even, when pro-
viders are willing to provide epidural analgesia, patients
in developing countries may resist. In Malaysia, patients
refused epidural analgesia because of fear, ignorance,
resistance by their husbands, religious reasons, lack of
knowledge about the procedure, and poor feedback from
friends [24].
In our experience, patients were reluctant to have epidural
analgesia because of their desire to have a natural child-
birth and their fears about developing back pain and
paralysis. Once epidural analgesia was initiated, we used
our method of delivery because (1) patients did not want
the physician to leave their bedside; (2) epidural pumps
were not available; (3) bupivacaine was not available,
when the study was initiated; and (4) obstetric co-workers
lacked experience with epidurals.
There are some points that make this study stand out from
the other trials randomizing laboring women to epidural
vs. opioid analgesia: The meperidine dose was quite
small. In contrast, most of the randomized trials from the
developed world use very large opioid dosage. The cervix
was examined hourly. In the developed world, cervical
Table 3: Method of Delivery
Factor Epidural Analgesia N = 197 Meperidine Analgesia N = 198 P value
NVD 169 (85) 175 (88) NS
VACUUM 4 (2) 4 (2) NS
C/S (dystocia) 8 (4) 8 (4) NS
C/S(Bradycardia) 16 (8) 11 (5) NS
Data are N (%)
NS = Not Significant
Table 4: Apgar Score of Neonates
Apgar Epidural N = 197 Meperidine N = 198 P value
First minute <7 8 1 NS
Fifth minute <7 7 2 NS
Data are N
NS = Not SignificantBMC Anesthesiology 2006, 6:15 http://www.biomedcentral.com/1471-2253/6/15
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exams are now infrequent. The reported first stage labor
lengths therefore are quite accurate. Analgesia was initi-
ated at a uniform cervical dilation. This is unusual in trials
from the developed world. While crossovers confound
many studies, this study was free from crossover.
Even in those views, which in contrary to mine, insist that
epidurals prolong the second stage of labor, it is stated
that the length of the second stage, even in those lasting
up to 6 hours or more, was not related to infant outcome
[25].
In summary, lumbar epidural analgesia with 1% lidocaine
does not prolong the active-first and second stages of
labor and does not increase the vacuum-assisted or cesar-
ean delivery rate, when compared with intravenous mepe-
ridine. Epidural labor analgesia can be delivered, even in
communities with significant economic, cultural and reli-
gious barriers to this technique. The higher intensity of the
motor block of lidocaine was not associated with any
harm in terms of obstetric outcome, duration of the sec-
ond stage of labor, obstetric intervention or neonatal out-
come.
Conclusion
Several studies have helped to confirm the opinion of
most anesthesiologists and obstetricians that epidural
analgesia only minimally lengthens labor and does not
increase the risk of cesarean section.
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